IL1B and schizophrenia: Li et al. reported that TLR4/NF-κB/IL-1β signaling (an essential pathway of innate immunity) is less responsive to LPS stimulation in patients with schizophrenia [51], which is consistent with our results that the downregulation of gene sets controlled by LPS is associated with severity of schizophrenia symptoms.